Genetic Technologies Inventory

Genetic Technologies's inventory stands at $210K as of June 2024. That compares with $330K in the prior-year period — down 36.6% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Genetic Technologies reported $210K in inventory versus $330K a year earlier — a 36.6% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $330K in the prior-year period — down 36.6% year over year. Sustained growth in inventory can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Genetic Technologies's inventory evolved across reporting periods, while the comparison chart places GENE next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, inventory is commonly used to spot outliers. Genetic Technologies's reading of $210K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.